Search Menu
Photonics Media Photonics Marketplace Photonics Spectra BioPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook

Mauna Kea Miniprobe Receives FDA Clearance

Facebook Twitter LinkedIn Email
PARIS, June 2, 2016 — Microscopy developer Mauna Kea Technologies SA has received its twelfth 510(k) clearance from the U.S. Food and Drug Administration (FDA).

The new FDA clearance covers its confocal miniprobes for use in urological and minimally invasive surgical applications with its NIR (near-infrared) Cellvizio platform. The company said its NIR imaging products are designed to provide a positive impact on procedural outcomes by adding the precision and reliability of real-time cellular characterization to fluorescence-guided procedures.

Mauna Kea is a global medical device company focused on the diagnosis and treatment of cancer through in vivo microscopic visualization.
Jun 2016
BusinessEuropeFranceBiophotonicsMauna KeaimagingFDAdistributionconfocal miniprobeurologyCellvizioNIR

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2023 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, [email protected]

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.